Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease

Kim, Jun PyoKim, Bo‑HyunBice, Paula J.Seo, Sang WonBennett, David A.Saykin, Andrew J.Nho, KwangsikAlzheimer’s Disease Neuroimaging Initiative2023-04-242023-04-242022-01-20Kim JP, Kim BH, Bice PJ, et al. Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer's disease. Alzheimers Res Ther. 2022;14(1):13. Published 2022 Jan 20. doi:10.1186/s13195-022-00960-6https://hdl.handle.net/1805/32546Erratum for: BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer's disease. Kim JP, Kim BH, Bice PJ, Seo SW, Bennett DA, Saykin AJ, Nho K; Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Res Ther. 2021 Oct 5;13(1):164. doi: 10.1186/s13195-021-00906-4. PMID: 34610832en-USAttribution 4.0 InternationalErratumAlzheimer’s diseaseAmyloidCognitionNeurogeneticsCorrection to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s diseaseArticle